The expression of survivin, which is a Wnt–CBP–β-catenin-regulated gene [149], is crucial during hematopoiesis [150], as well as leukemogenesis [137,151] and CML and the downregulation of survivin [137,148]. The gene discussed is BIRC5; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.